KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Edwards Lifesciences (EW) over the last 12 years, with Q3 2025 value amounting to $90.4 million.

  • Edwards Lifesciences' Restructuring Costs rose 17477.2% to $90.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.9 million, marking a year-over-year increase of 14230.77%. This contributed to the annual value of $61.0 million for FY2024, which is 7002.46% down from last year.
  • Latest data reveals that Edwards Lifesciences reported Restructuring Costs of $90.4 million as of Q3 2025, which was up 17477.2% from $15.5 million recorded in Q2 2025.
  • Edwards Lifesciences' Restructuring Costs' 5-year high stood at $147.9 million during Q2 2023, with a 5-year trough of -$2.4 million in Q3 2022.
  • For the 5-year period, Edwards Lifesciences' Restructuring Costs averaged around $24.9 million, with its median value being $8.9 million (2024).
  • In the last 5 years, Edwards Lifesciences' Restructuring Costs crashed by 15106.38% in 2022 and then skyrocketed by 232459.02% in 2023.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Restructuring Costs stood at $7.1 million in 2021, then skyrocketed by 602.82% to $49.9 million in 2022, then tumbled by 80.16% to $9.9 million in 2023, then surged by 183.84% to $28.1 million in 2024, then soared by 221.71% to $90.4 million in 2025.
  • Its Restructuring Costs stands at $90.4 million for Q3 2025, versus $15.5 million for Q2 2025 and $10.9 million for Q1 2025.